Mesoblast share price logo

Mesoblast

NASDAQ: MESO

Small Cap

$13.95

+0.16

(+1.16%)

as on

Mesoblast Stock Performance

as on October 16, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $13.55
    $14.00
    downward going graph

    2.87%

    Downside

    0.36%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $13.05
    $21.50
    downward going graph

    6.45%

    Downside

    54.12%

    Upside

    downward going graph

Mesoblast share price movements today

Previous Close
$13.79
Open
$13.55
Volume
230.6K
Market Cap
$1.8B
Day's Low - High
$13.55 - $14.00
52 Week Low - High
$13.05 - $21.50

Mesoblast Historical Returns

1 Month Return
-3.19 %
3 Month Return
-21.89 %
1 Year Return
-22.89 %
3 Year Return
+ 462.5 %
5 Year Return
+ 22.8 %

Mesoblast Stock Fundamentals & Key Indicators

Check Mesoblast market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

-0.4338

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-27.68

Industry PE ratio

-9.84

PEG Ratio

-0.39

EBITDA

-43.7M

Revenue (TTM)

120.8M

Profit Margin

78.30%

Return On Equity TTM

-10.06%

Mesoblast vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mesoblast with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$1.8B22.80%-27.6878.30%0.00%
Neutral$90.3B-27.05%-29.64-12.57%0.00%
StrongBuy$126.4B179.89%28.7886.04%0.00%
Buy$77.5B43.94%19.0184.86%0.48%

Stock Returns calculator for Mesoblast Stock including INR - Dollar returns

The Mesoblast stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mesoblast investment value today

Current value as on today

₹83,477

Returns

-₹16,523

(-16.52%)

Returns from Mesoblast Stock

-₹22,886 (-22.89%)

Dollar Impact

₹6,363 (+6.36%)

Analyst Recommendation on Mesoblast Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Mesoblast. Average target price of $37

Mesoblast Share Price Target

Get share price movements and forecasts by analysts on Mesoblast.

What analysts predicted

62.3%UPSIDE

Target Price

$37

Current Price

$13.95

Analyzed by

1 Analysts

High

$39

Target

$37.00

Low

$39

Mesoblast target price $37, a slight upside of 62.3% compared to current price of $13.95. According to 1 analysts rating.

Indian Investors' Interest in Mesoblast Stock

Search interest for Mesoblast Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-54% versus previous 30 day period

Mesoblast Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
1
1
1
7
7
25
25
34
34
Gross Profit
-9
-9
-1
-1
-16
-16
-1
-1
49
49
Operating Income
-22
-22
-20
-20
-34
-34
-38
-38
-20
-20
EBITDA
-14
-14
-8
-8
-19
-19
-12
-12
-9
-9
Interest Expense
4
4
5
5
-
-
5
5
-
-
Depreciation
1
1
1
1
2
2
1
1
2
2
Income Before Tax
-27
-27
-23
-23
-27
-27
-19
-19
-8
-8
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-27
-27
-23
-23
-27
-27
-20
-20
-8
-8
Net Profit Margin
-762.25%
-762.25%
-107.85%
-107.85%
-231.13%
-231.13%
-4.72%
-4.72%
143.16%
140.96%

Mesoblast Annual Profit & Loss

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Total Revenue
2
17
16
32
7
10
7
5
17
120
Gross Profit
-9
11
-58
-49
-78
-53
-47
-35
12
101
Operating Income
-90
-77
-80
-74
-109
-80
-69
-84
-62
-51
EBITDA
-87
-74
-84
-68
-84
-76
-58
-53
-73
-42
Interest Expense
-
1
11
14
10
17
19
20
22
23
Depreciation
3
2
2
3
4
4
4
4
6
8
Income Before Tax
-90
-65
-98
-87
-99
-91
-82
-88
-101
-57
Income Tax Expense
-13
-30
-8
-9
0
0
0
0
0
0
Net Income
-76
-35
-89
-77
-98
-91
-81
-87
-102
-57
Net Profit Margin
-400.21%
68.24%
-349.55%
-153.44%
-1049.83%
-522.58%
-632.20%
-595.87%
70.17%
84.09%

Mesoblast Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-27
-27
-23
-23
-27
-27
-
-
-
-8
Operating Cash Flow
-11
-10
-10
-10
-12
-14
-14
-15
-4
-6
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
11
-3
-1
-2
156
-4
-1
0
-4
-9
Change in Cash
-1
-13
-11
-13
144
-20
-16
-14
-8
-18

Mesoblast Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Net Income
-76
-35
-89
-77
-98
-91
-81
-87
-102
-
Operating Cash Flow
-95
-75
-57
-56
-106
-65
-63
-48
-49
-43
Investing Cash Flow
0
-1
-1
-3
-1
0
0
0
0
-1
Financing Cash Flow
60
68
71
137
114
-9
74
40
147
-15
Change in Cash
-35
-7
12
78
7
-76
10
-8
98
-58

Global Institutional Holdings in Mesoblast

Check out the Institutions with significant holdings in Mesoblast.

Funds
Holdings
iShares
0.51%
Fidelity Concord Street Trust
0.02%
ActivePassive
0.01%
Invesco
0.01%
Steward Funds Inc
0.01%

Insights on Mesoblast

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 5 quarters, -27.10M → -8.66M (in $), with an average increase of 41.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 9 quarters, 1.25M → 34.99M (in $), with an average increase of 24.7% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MESO has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, MESO stock has moved up by 462.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 771.4% return, outperforming this stock by 794.3%

About Mesoblast

Mesoblast Limited is a biopharmaceutical firm dedicated to the development and commercialization of allogeneic cell-based therapies. Its global presence extends across the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company addresses a broad spectrum of medical conditions, including cardiovascular, spinal orthopedic disorders, oncology, hematology, and immune-mediated and inflammatory diseases. At the core of its innovation is a proprietary regenerative medicine platform utilizing specialized mesenchymal lineage cells. Currently, several of Mesoblast's leading product candidates are undergoing Phase III clinical trials: remestemcel-L, designed for severe, steroid-refractory acute graft versus host disease and acute respiratory distress syndrome associated with COVID-19; Rexlemestrocel-L, aimed at advanced chronic heart failure; and MPC-06-ID, intended for chronic low back pain stemming from degenerative disc disease. Additionally, MPC-300-IV is being developed for biologic-refractory rheumatoid arthritis and diabetic nephropathy. The company has cultivated strategic partnerships to advance its pipeline and market reach. These collaborations include Tasly Pharmaceutical Group for the distribution of MPC-150-IM (heart failure) and MPC-25-IC (heart attacks) in China; JCR Pharmaceuticals Co. Ltd. for therapies addressing wound healing in patients with epidermolysis bullosa; and Grünenthal for the development and commercialization of cell therapy solutions for chronic low back pain. Mesoblast Limited was established in 2004 and maintains its headquarters in Melbourne, Australia.
OrganisationMesoblast
Headquarters55 Collins Street, Melbourne, VIC, 3000, AU
IndustryBiotechnology
CEOSilviu Itescu

Key Management of Mesoblast

Name

Title

Mr. Anthony Wheal

Head of Human Resources

Ms. Geraldine Storton B.Sc., M.B.A., MMS

Head of Regulatory Affairs & Quality Management

Mr. Justin Horst B.S.

Head of Manufacturing

Dr. Fiona See Ph.D.

Senior VP & Head of Translational Research

Mr. Marcelo Santoro

Chief Commercial Officer

Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons)

Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director

Dr. Eric A. Rose M.D.

Chief Medical Officer & Executive Director

Mr. Paul Hughes BPHARM

Global Head of Corporate Communications & Joint Company Secretary

Dr. Paul J. Simmons BSc, Ph.D.

Scientific Advisor to the Chief Executive Officer

Mr. Daniel Devine B.Sc., J.D., M.B.A

Head of Special Projects

FAQs

What is Mesoblast share price today?

Mesoblast share price today is $13.95 as on at the close of the market. Mesoblast share today touched a day high of $14.00 and a low of $13.55.

What is the 52 week high and 52 week low for Mesoblast share?

Mesoblast share touched a 52 week high of $21.50 on and a 52 week low of $13.05 on . Mesoblast stock price today i.e. is closed at $13.95,which is 35.12% down from its 52 week high and 6.90% up from its 52 week low.

What is Mesoblast's market capitalisation today?

Mesoblast market capitalisation is $0.00T as on .

How to invest in Mesoblast Stock (MESO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Mesoblast on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Mesoblast Stock (MESO) from India?

Indian investors can start investing in Mesoblast (MESO) shares with as little as ₹95.05500030517578 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.55 in Mesoblast stock (as per the Rupee-Dollar exchange rate as on ). Based on Mesoblast share’s latest price of $13.95 as on October 16, 2026 at 8:46 am IST, you will get 0.7168 shares of Mesoblast. Learn more about fractional shares .

What are the returns that Mesoblast has given to Indian investors in the last 5 years?

Mesoblast stock has given 22.8% share price returns and 27.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?